Lately, several publications have focused on circadian rhythms and sleep in patients with disorders of consciousness (DOC), namely patients who, following severe brain injury, are in an unresponsive wakefulness syndrome/a vegetative state (UWS/VS) or in a minimally conscious state (MCS) (Cologan et al., 2013; de Biase et al., 2014; Forgacs et al., 2014; Landsness et al., 2011; Pavlov et al., 2017; Rossi Sebastiano et al., 2018) . Circadian rhythms, i.e., variations in biological processes with a period length of about 24 hours, have been discovered in virtually all biological organisms. In humans, they have also been shown to affect cognitive functions (Chellappa, et al., 2018 ; for a review see Schmidt, et al., 2007) .
Several publications have also emphasized the significance of deviations from "healthy" circadian rhythmicity in clinical populations (e.g. Blume et al., 2017; Gehlbach et al., 2012; Mundigler et al., 2002) and piloted e.g. bright light exposure to counteract circadian misalignment (Blume et al., 2017) . While we very much appreciate that the field increasingly recognizes the importance of circadian rhythms or sleep-wake cycling in DOC patients, we believe that two manuscripts recently published in this journal by Rossi Sebastiano et al.
(2018) and Kotchoubey and Pavlov (2018) deserve further attention and discussion.
First, it seems important to clarify the relationship between circadian rhythms (i.e. ≈ 24 h), ultradian rhythms (< 24 h) and the sleep-wake cycle. True, alternations between sleep and wakefulness across the 24 h day certainly represent one prominent manifestation of circadian rhythms. However, as studies in DOC patients often only monitor sleep during the night and not the full sleep-wake cycle (Landsness et al., 2011: 12 h, 8 pm-8 am; Rossi Sebastiano et al., 2018: 12 h, 8 pm-8 am;  cf. Table 2 for the recording times), we would like to emphasize that this renders conclusions about ≈ 24 h circadian rhythms, as drawn e.g., by Kotchoubey and Pavlov (2018) , illegitimate. Importantly, the mere alternations between sleep stages do not indicate circadian rhythmicity, but they represent an ultradian rhythm, i.e., a rhythm with a period length shorter than 24 h. It is evident that there are only very few studies, and with widely varying criteria, which actually allow to evaluate circadian rhythms in DOC (cf. Table 1 ).
[Please insert Table 1 about here] Moreover, recording data across 24 h may be sufficient in healthy individuals, but not necessarily so in brain-injured patients. The "gold standard" of circadian rhythm assessment in healthy participants foresees the assessment of a full melatonin cycle, which should be measured hourly for at least 24 h (Middleton, 2013) . In clinical populations, however, the circadian period length can be pathologically prolonged (e.g., in severely brain-injured patients: Blume et al., 2017: 23.5-26.3 h; or according to Matsumoto et al., 2013: 6-63 h) . If this is suspected, rhythms must evidently be monitored for more than 24 h. Optimally, the assessment of circadian rhythms in clinical groups, where different manifestations of circadian rhythms may even become uncoupled, should also take into account additional measures. More specifically, besides the melatonin rhythm, recordings of core body or skin temperature (or even actigraphy) may represent further manifestations of circadian rhythms and thus valuable sources of information. However, the usually rather noisy nature of such data requires measurements over at least several days to achieve an adequate signal-to-noise ratio for reliable conclusions. In previous studies investigating variations in body temperature, Bekinschtein et al. (2009) for example monitored rhythmicity across 13-16 days in a small sample of five patients and found a circadian rhythm in two patients. In another study Matsumoto et al. (2013) recorded temperature across 72 hours and found circadian variations in seven out of ten patients and a 6, 12 and 63 h rhythm in the other three. Recently, Blume et al. (2017) found circadian rhythms (23.5-26.3 h) in all patients when using sensitive LombScargle periodograms for data analysis of continuously monitored body temperature across 6-7 days. Investigating variations in activity levels (using actigraphy for a minimum of 4 days), Cruse et al. (2013) reported circadian variations in physical activity in 46 out of 55 patients.
In this latter study, it remained however unclear to what extent nursing activity or interactions with visitors may have influenced the actigraphy-recorded data across the analyzed day-night cycle.
An additional problem when recording sleep in clinical populations is that it is questionable whether sleep is indeed limited to the night, especially in severely impaired patients (in a sometimes rather sleep-hostile nocturnal hospital environment) and with an unusual constant sleep opportunity across 24 h (Parthasarathy and Tobin, 2004) . Rossi Sebastiano et al. (2018) report that in DOC patients the average duration of sleep during a 12 h night was only 3.2 h (VS/UWS: 155 ± 89 min; MCS: 230 ± 123 min). Even though the authors state they did not include stage N1 sleep, this seems extremely little and might indicate that sleep in this population did not exclusively take place during the night. The necessity to investigate sleep across night and day, i.e. 24 h, is further underlined by recent findings from our group.
Specifically, Wislowska et al. (2017) and Wielek et al. (2018) used ≈24 h polysomnography (PSG) recordings for the assessment of circadian rhythmicity in DOC patients. Using infrared videography, Wislowska et al. (2017) found that DOC patients presented with open eyes for 51±30% of the day-time and 45±40% of the night-time, clearly contrasting a healthy circadian behaviour; also, sleep spindles and slow waves were observable to the same degree during night as well as day. Along the same lines, Wielek et al. (2018) found that VS/UWS and MCS patients presented with (statistically) indistinguishable amounts of sleep (here, N2-N3 and REM) during both day and night (day sleep: VS/UWS: 55 ± 40%, MCS: 50 ± 35%; night sleep: VS/UWS: 67 ± 37%, MCS: 61 ± 26%). Only using a more complex computational approach, we found that EEG complexity as measured by entropy slightly decreased from day-time to night-time (1.4% drop in VS/UWS with p=.07, and 1.9% drop in MCS with p=.02). Yet this difference was much less pronounced than in healthy subjects falling asleep (4.9% drop in signal complexity from wakefulness to sleep with p<.01; Wislowska et al., 2017) .
A second and unresolved issue is how sleep in DOC patients is best scored or classified. Approaches that have been used in the past can roughly be split into two groups, namely (i) approaches based on the application of explicit rules that have directly been derived from scoring systems for healthy sleep such as the Rechtschaffen and Kales (1968) or the more recent AASM criteria (American Academy of Sleep Medicine & Iber, 2007) and (ii) data-driven approaches that aim at increasing objectivity and replicability by solely learning from the data itself. As even Kotchoubey and Pavlov (2018) point out, the problem with the first group of approaches is that standard scoring criteria usually cannot be applied to pathological states and thus need significant adjustment. This results in highly subjective criteria that moreover significantly differ between studies or research groups, rendering results largely non-replicable (e.g. what is considered "real sleep" or "pathological background" slow-wave activity?, when and why do raters switch between channels or even hemispheres?, etc.; cf. Table 2 for an overview of the criteria employed). Sleep staging in brain-injured patients requires exceptional sleep expertise of (blinded) raters. This is because (manual) sleep staging heavily relies on visual judgements and experience with brain activity following severe injury often being only remotely reminiscent of what we are used to observe in healthy individuals. The degree of adaptation of the criteria sometimes renders it hard to even recognize on which norms they have originally been based (i.e. American Academy of Sleep Medicine and Iber (2007) or Rechtschaffen and Kales (1968) , cf. Table 2 ). To give an example, Rossi Sebastiano et al. (2018) also considered "repeated diffuse transients associated with fragments of alpha-theta activity" as indicators of N2 sleep, whereas AASM criteria require the presence of sleep spindles or K-complexes. Moreover, they define a new category called "attenuation" and, also, their definition of slow wave sleep (SWS) deviates from standard criteria with also small-amplitude <75 µV slow waves being taken as evidence for SWS. Besides this, definitions of sleep spindles (usually: 0.5-2 s; cf. e.g. Heib et al., 2015) strongly differ between the abovementioned studies (e.g. Pavlov et al. (2017) : similar to AASM with 11-16 Hz and 0.5-3 s, but in Rossi Sebastiano et al. (2018) : also "atypical slow (10-12 Hz) spindles of long duration (>5 s)" are considered; also see Table 2 ). Given these differences in scoring criteria it is little surprising that even the mere presence or absence of key features of sleep vary considerably between studies (e.g., sleep spindles present in VS/UWS 0-56%, SWS present in VS/UWS: 0-78%, or REM present in VS/UWS: 0-67%; cf. Table 2 ).
[Please insert Table 2 about here] While we agree that scoring of sleep in DOC patients is extremely challenging, we wonder whether "bending" standardized scoring criteria to make data "stageable" is useful in the first place and if researchers not rather should (i) agree on common sleep-staging criteria for DOC or (ii) strive for developing and using more data-driven approaches. Data-driven approaches do not allow for "classical" sleep staging, yet they have the major advantage of replicability and they are more robust against artefacts. In Wislowska et al. (2017) for example we explicitly refrained from manual sleep staging and rather categorized the 24 h data into night/"lights off" and day/"lights on" periods. Subsequently, we applied spectral measures as well as measures of signal complexity (permutation entropy), which have previously been shown to be good indicators of DOC patients' states (cf. Sitt et al., 2014) , along with an automatic and algorithm-based detection of sleep spindles (Anderer et al., 2005) and slow oscillations (Riedner et al., 2011) .
Regarding automatic sleep-staging, several well-established algorithms exist (Anderer et al., 2005; Berthomier et al., 2007) . While they do yield replicable results, their usefulness in severely brain-injured patients is questionable since they heavily rely on classical criteria developed for healthy brain signals. Thus, in Wielek et al. (2018) we recently adopted a datadriven classification approach. More specifically, we trained a multivariate classifier on healthy participants' sleep data (which had previously been staged according to AASM criteria) and the classifier then staged sleep in new datasets acquired from DOC patients according to the data-derived staging criteria. Results were then cross-checked by comparing the scoring with the state of the patient's eyes using the available (infrared) videos. In 11 out of 23 patients the classification was highly accurate and only in four patients there was an obvious mismatch between sleep staging and the state of the eyes. From a proof-of-principle perspective this indicates that refining data-driven approaches may be a good choice for sleep staging of extremely challenging datasets, such as encountered in DOC patients.
Another interesting approach called "matching pursuit" technique is presented by Malinowska et al. (2013) . Although the aim of this approach is not sleep staging in the classical sense, it allows detecting relevant structures in the sleep EEG such as sleep spindles, K-complexes or delta activity, i.e. elements included in the scoring schemes.
In summary, we believe that scientists working on sleep and/or circadian rhythms in severely brain-injured patients should strive to agree on (i) acceptable circadian measures allowing for valid conclusions (e.g. hourly melatonin measurements or temperature sampling across several days), and (ii) develop staging standards for the analysis of sleep data in braininjured patients. A special interest group such as the "Disorders of Consciousness Special Interest Group" of the International Brain Injury Association (DOC-SIG) might represent a suitable platform. Beyond this, we should also aim at substantially sized multi-centric studies in order to meaningfully relate a variety of structural changes in this heterogeneous population to deviations in sleep patterns, or even assess whether reliable diagnostic and prognostic statements can be derived from such data. Data from our group (Wislowska et al., 2017) for example relate the density of sleep spindles (and by trend also higher alpha-to-theta EEG ratios) to a positive outcome (i.e. lower risk to pass away) and Valente et al. (2002) and Arnaldi et al. (2016) suggested earlier that more complex sleep architecture (i.e., wellstructured NREM and/or REM sleep elements) in DOC patients predicted better clinical outcome.
Ultimately, further knowledge about sleep and circadian rhythms in these patients will guide us to consider new treatment options. One such approach could aim at a clearer delineation of day and night in the hospital or care-home environment with the aim of better aligning to the circadian day and increasing daytime arousal and responsiveness. In this context, stimulation with blue-enriched bright light may be one such promising candidate. 
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